FDA Guidance for Industry – Q1A(R2) Stability Testing of Drug Substances and Products
FDA Guidance for Industry The “FDA Guidance for Industry: Q1A(R2) Stability Testing of Drug Substances and Products” provides essential recommendations and requirements for conducting stability testing of drug substances and products. This guidance plays a crucial role in ensuring the safety, efficacy, and quality of pharmaceuticals throughout their intended shelf-life. By establishing standardized stability testing…
Read More “FDA Guidance for Industry – Q1A(R2) Stability Testing of Drug Substances and Products” »